News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tissue Regeneration Therapeutics Inc. Receives Defense Acquisition Challenge Grant


11/17/2008 11:53:41 AM

WOODSTOCK, Ga.--(BUSINESS WIRE)--Tissue Regeneration Technologies, LLC (TRT) is proud to announce the receipt of a $2 million grant from the Defense Acquisition Challenge (DAC) for fiscal year 2009. TRT's proposal "Shockwave Therapy for Traumatic Wounds of the Extremity" is designed to evaluate the effectiveness of shockwave therapy in treating complex wounds in a combat casualty care venue. TRT's Department of Defense partner, the Combat Wound Initiative (CWI) Program, is currently spearheading a randomized clinical trial evaluating the efficacy of shock wave therapy.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES